[{"Assets_0_Q2_USD":26287600000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":3423500000.0,"NetIncomeLoss_1_Q2_USD":1494100000.0,"NetIncomeLoss_2_Q2_USD":2902900000.0,"StockholdersEquity_0_Q2_USD":12952900000.0,"EarningsPerShareBasic_1_Q2_USD":7.85,"EarningsPerShareBasic_2_Q2_USD":15.01,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":190300000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":193400000.0,"Ticker":"BIIB","CIK":"875045","name":"BIOGEN INC.","OfficialName":"Biogen Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"32775642095.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20190724"}]